Thuja Capital Healthcare Fund II will support commercialisation of research at Utrecht University, University Medical Center Utrecht and Radboud University Medical Center.
Thuja Capital Management, a Netherlands-based VC firm, has launched a €34m ($38m) fund backed by the European Investment Fund, the EU agency responsible for financing SMEs, and private investors.
Thuja Capital Healthcare Fund II plans to invest in companies that create products that improve diagnosis of diseases, cure or care for patients and that contribute to reducing the cost of healthcare.
Investments will be focused on Netherlands and Belgium-based companies.
The fund has partnered Utrecht University, University Medical Center Utrecht and Radboud University Medical Center and Regional Development Agencies.
Thuja will work with the universities’ tech transfer offices to help commercialise research.
– This article first appeared on our sister site Global Government Venturing.
